QuantumScape price target lowered to $6 from $7 at Truist

Truist lowered the firm’s price target on QuantumScape to $6 from $7 and keeps a Hold rating on the shares. The company looks to continue to progress its efforts in bringing its first commercial cell product to market, but the current market backdrop for pre-revenue battery players amid rising rates remains challenging, the analyst tells investors in a research note.